Treatment success rate and time to culture conversion under a prospective BPaL cohort study.

Saved in:
Bibliographic Details
Title: Treatment success rate and time to culture conversion under a prospective BPaL cohort study.
Authors: Burhan E; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.; Persahabatan Hospital, Jakarta, Indonesia., Sugiharto J; Yayasan KNCV Indonesia, Jakarta, Indonesia., Soemarno M; Yayasan KNCV Indonesia, Jakarta, Indonesia., Juan A; Yayasan KNCV Indonesia, Jakarta, Indonesia., Runtu Y; Yayasan KNCV Indonesia, Jakarta, Indonesia., Yuvensia A; Yayasan KNCV Indonesia, Jakarta, Indonesia., Ramadhani R; Yayasan KNCV Indonesia, Jakarta, Indonesia., Sabono J; Yayasan KNCV Indonesia, Jakarta, Indonesia., Lailiyah A; Yayasan KNCV Indonesia, Jakarta, Indonesia., Fenni F; Yayasan KNCV Indonesia, Jakarta, Indonesia., Farikha M; National Tuberculosis Programme, Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia., Pakasi T; National Tuberculosis Programme, Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia., Pambudi I; Directorate of Mental Health, Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia., Mbenga M; Division of TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands., Koppelaar I; Inpatient Care, Lelie Care Group, Rotterdam, The Netherlands., Mirtskhulava V; Division of TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands.; Faculty of Natural Sciences and Medicine, Ilia State University, Tbilisi, Georgia., Wares F; Division of TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, Worthing, UK., Jerene D; Division of TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands., Jung JK; Division of Global Health, International Tuberculosis Research Center, Changwon, Republic of Korea., Lee JS; Division of Microbiology, International Tuberculosis Research Center, Changwon, Republic of Korea., Foraida S; Research and Development, TB Alliance, New York, NY, USA., Juneja S; Market Access, TB Alliance, New York, NY, USA., Diachenko M; Market Access, TB Alliance, New York, NY, USA., Gebhard A; Division of TB Elimination and Health Systems Innovations, KNCV Tuberculosis Foundation, The Hague, The Netherlands.
Source: IJTLD open [IJTLD Open] 2025 May 12; Vol. 2 (5), pp. 284-290. Date of Electronic Publication: 2025 May 12 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9918803487706676 Publication Model: eCollection Cited Medium: Internet ISSN: 3005-7590 (Electronic) Linking ISSN: 30057590 NLM ISO Abbreviation: IJTLD Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:3005-7590
DOI:10.5588/ijtldopen.24.0524